The US Food and Drug Administration (FDA) has approved Wezlana (ustekinumab-auub) as…
Invimeds HealthNovember 2, 2023
News2
To become most Valued & Trusted partner for access to medicines. Driven by Knowledge and Services, InviMeds to become essential to its customers by providing access to most advanced treatment medicines and related services to help improve people’s quality of life.
© 2023 Invimeds. All Rights Reserved.